Nuzenio

Genmab

Genmab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Fri, 07 Aug 2026 19:41:15 GMTIs Johnson & Johnson (JNJ) Fully Valued On Darzalex Royalty Strength? - simplywall.st
Fri, 07 Aug 2026 18:06:28 GMTGenmab (CPSE:GMAB) Stock Revenue Strength Meets Profit Pressure - simplywall.st
Fri, 07 Aug 2026 13:12:09 GMTGenmab: Q2 beat reinforces the investment story; diversification efforts remain on course - marketscreener.com
Fri, 07 Aug 2026 06:11:08 GMTAnalyst notes several bright spots in guidance upgrade: "Genmab is focusing on the right areas" - medwatch.com
Fri, 07 Aug 2026 05:29:18 GMTNordea raises its target price for Genmab to 2,083 Danish kroner (2,015), reiterates buy - marketscreener.com
Fri, 07 Aug 2026 01:52:00 GMTGenmab (GMAB) Q2 2026 Earnings Call Transcript - The Motley Fool

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Genmab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.